key: cord-0972468-4eklkwsa
authors: Gale, Paul
title: Using thermodynamic parameters to calibrate a mechanistic dose-response for infection of a host by a virus
date: 2018-01-04
journal: Microb Risk Anal
DOI: 10.1016/j.mran.2018.01.002
sha: 1a3f45ac97281b2eec0d578f579186849c7acbe1
doc_id: 972468
cord_uid: 4eklkwsa

Assessing the risk of infection from emerging viruses or of existing viruses jumping the species barrier into novel hosts is limited by the lack of dose response data. The initial stages of the infection of a host by a virus involve a series of specific contact interactions between molecules in the host and on the virus surface. The strength of the interaction is quantified in the literature by the dissociation constant (K(d)) which is determined experimentally and is specific for a given virus molecule/host molecule combination. Here, two stages of the initial infection process of host intestinal cells are modelled, namely escape of the virus in the oral challenge dose from the innate host defenses (e.g. mucin proteins in mucus) and the subsequent binding of any surviving virus to receptor molecules on the surface of the host epithelial cells. The strength of virus binding to host cells and to mucins may be quantified by the association constants, K(a) and K(mucin), respectively. Here, a mechanistic dose-response model for the probability of infection of a host by a given virus dose is constructed using K(a) and K(mucin) which may be derived from published K(d) values taking into account the number of specific molecular interactions. It is shown that the effectiveness of the mucus barrier is determined not only by the amount of mucin but also by the magnitude of K(mucin). At very high K(mucin) values, slight excesses of mucin over virus are sufficient to remove all the virus according to the model. At lower K(mucin) values, high numbers of virus may escape even with large excesses of mucin. The output from the mechanistic model is the probability (p(1)) of infection by a single virion which is the parameter used in conventional dose-response models to predict the risk of infection of the host from the ingested dose. It is shown here how differences in K(a) (due to molecular differences in an emerging virus strain or new host) affect p(1), and how these differences in K(a) may be quantified in terms of two thermodynamic parameters, namely enthalpy and entropy. This provides the theoretical link between sequencing data and risk of infection. Lack of data on entropy is a limitation at present and may also affect our interpretation of K(d) in terms of infectivity. It is concluded that thermodynamic approaches have a major contribution to make in developing dose-response models for emerging viruses.

Microbiological risk assessment (MRA) requires a dose-response relationship to translate the exposure (i.e. number of pathogen particles entering the host through a given route) into the probability of infection. Infection by an oral pathogen is defined as the multiplication of organisms within the host, followed by excretion (Haas et al., 1999) and, for the purpose of the work here does not include progression of disease or the host acquired immune response. Obtaining dose-response data for humans has generally relied on volunteer challenge experiments e.g. Cryptosporidium parvum in students (Okhuysen et al., 1998) or using outbreak data to back-calculate the relationship between measured exposures and infection rates (Teunis et al., 2004) . There are limitations to both approaches particularly with emerging pathogens for which the exposure routes may not be fully elucidated, and for pathogens with serious clinical outcomes, e.g. Zaire ebolavirus (EBOV). Furthermore zoonotic viruses emerge through jumping the species barrier from an animal source to humans, e.g. Nipah virus (NiV) and EBOV, and in this respect the dose response would be for a one-off event that may be inefficient and difficult to reproduce without large numbers of animals. An additional complication is that the pathogen may adapt to the new host, such that its infectivity increases. This is well established for filoviruses in laboratory animals where the infectivity per plaque-forming unit (pfu) may change by several orders of magnitude with passaging (Gale et al., 2016) , and has recently been demonstrated for EBOV Makona adapting to humans through an amino acid substitution in its glycoprotein during the recent catastrophic outbreak in West Africa (Diehl et al., 2016; Urbanowicz et al., 2016) . That outbreak also raised many questions regarding the unknown potential for companion animals (cats and dogs) to serve either as a reservoir or vector for the virus and so be involved in transmission of EBOV to humans and other animals. The absence of dose-response data for EBOV in humans limits development of MRAs for the risk of infection of citizens in the EU for example from EBOV in illegally imported bushmeat. Indeed, it has been proposed that the infectivity to humans of an EBOV pfu may differ not only from bushmeat samples from different wildlife species (e.g. fruits bats and nonhuman primates) but also from different individuals of the same species depending on the degree of host adaptation (Gale et al., 2016) . In effect no two pieces of bushmeat from EBOVinfected wildlife may be the same in terms of infectivity to humans, although this remains to be proved. There is clearly a need for novel approaches to calibrate dose-response relationships for the purposes of MRA for emerging pathogens.

The infection process of a host cell can be broken down into the component steps and modelled mathematically (Handel et al., 2014) and the probability of infection can be expressed as a function of the combined probabilities of each step (Gale et al., 2014) . These steps include overcoming the initial host defenses, binding of the virion to its host cell receptor, entry to the host cell (i.e. internalisation and uncoating of the virion), and replication, capsid assembly and budding (Gale et al., 2014) . Previously it was demonstrated that a dose-response model could, in part, be parameterized using thermodynamic data for some of the key molecular interactions in the infection process (Gale, 2017) . The beauty of thermodynamic data is that they can be measured experimentally by biochemists (in some cases just using molecular components e.g. cloned virus protein and host receptor protein (Wang et al., 2016) ) and do not involve live animal or human volunteer studies, which is a major advantage for dangerous pathogens. Furthermore the effect of amino acid substitutions in the host receptors on binding affinity can be measured directly (Yuan et al., 2015) . The possibility of applying thermodynamics is further developed here for two of the key steps in the infection process of a host by a virus. The first step modelled is the probability of the virus overcoming the innate host defenses posed by mucin protein molecules and the pathogen recognition receptors (PRRs) produced by the host. Mucins have sugar units on their surface which bind to components on the surface of the virus, for example the haemagglutinnin (HA) glycoprotein molecules of influenza virus (de Graaf and Fouchier, 2014) or the VP1 of norovirus (NoV) (de Rougemont et al., 2011) . Mucus present in the respiratory tract hampers influenza virus infection and in the case of humans predominantly contains α2,3-sialic acid receptors. Indeed influenza viruses with α2,3 specificity were inhibited by human mucins (de Graaf and Fouchier, 2014) . The PRRs include the mannose binding protein (MBP) which has carbohydrate-recognition domains (CRD) which bind to regularly repeating sugar units on pathogen surface (Taylor and Drickamer, 2006) . The second step modelled here is the binding of the virus to its specific receptors on the host cell surface. The approach here is developed for a generic faecal/oral virus such as NoV and rotavirus which infects epithelial cells lining the intestine (Boshuizen et al., 2005; de Rougemont et al., 2011) , but could be applied to influenza A viruses which are inhaled and infect cells of the trachea and lung (de Graaf and Fouchier, 2014) . This paper first gives an overview of a mechanistic dose response model to introduce two probability parameters, namely the fraction, F v , of virus escaping the mucin defense barrier and the fraction, F c , of host cells with bound virus. The Methods section sets out a difference equation method to model F v and F c as a function of the mucin: virus ratio and virus dose in the intestine, respectively. Central to determining F v and F c is the strength of binding of the virus to the mucin and host cell as defined by the equilibrium constants K mucin and K a respectively. In the Theory section, the application of published data on the binding of the virus surface envelop glycoprotein (GP) to host cell receptor (Cr) molecules or to mucin molecules is reviewed in terms of determining K mucin and K a in order to parameterize the dose-response. Particular reference is made to using the dissociation constant K d which is routinely determined experimentally for virus GPs binding to Cr molecules (Gambaryan et al., 2005; Raman et al., 2014; Yuan et al., 2016) . It is then shown how the strength of virus/host cell binding (i.e. the magnitude of K a ) may be predicted from changes in two thermodynamic parameters, namely enthalpy (H) and entropy (S). The effects of amino acid changes at the contact surfaces of the virus GP and Cr on the enthalpy are considered with a view to the future parameterization of dose-response models based on genetic sequencing data. Entropy changes are also considered both in terms of virus binding and also in the interpretation of K d data.

The model parameters and variables are summarised in Table 1 . On ingestion of the initial virus challenge dose, V initial , by the host there are a number of immediate host defences in the mouth and gastrointestinal (GI) tract including the mucus barrier, decoy receptors and the innate immune system that selectively bind and hence remove the virus (McGuckin et al., 2011) . For example the histoblood group antigens (HBGAs) are genetically determined glycans to which NoV selectively binds and are present on both decoy receptors in the saliva and on mucin, the main protein component of mucus (Shanker et al., 2011) . The total number of viruses surviving the mucin barrier, and getting through to the intestine is given by

where F v is the fraction of free virus, i.e. that not bound to mucin. As shown in Fig. 1 , F v can be modelled by two parameters, namely the total number, Muc total , of mucin molecules in the mucus in the saliva and GI tract and an association constant, K mucin (defined below) that quantifies the strength of binding of the virus to a mucin molecule. Thus by inserting F v from Fig. 1 for a given mucin concentration into Eq. (1), the total number of free virus particles in the intestine and available to initiate infection of the epithelium may be modelled. On reaching the intestinal epithelium, a free virus particle binds to the surface of a host cell. The probability of infection of the host, p host , equals the probability of successful infection of at least one cell and is related to the number of cells (C.V) with bound virus by:-

where p cell is the probability of successful infection of a host cell given a virus has bound to its surface. Thus the more cells with bound virus then the greater the chance that infection will be successful in at least one of them. The probability p cell depends on ability of the bound virus to enter the cell, replicate and bud (Gale et al., 2014; Gale, 2017) and is not discussed further here. Now

where F c is the fraction of cells with bound virus, and C total is the number of cells in the host intestinal epithelium. As shown in Fig. 2 , F c is directly proportional to the total number of virus particles in the intestine, V intestine , and is also dependent on the strength of the binding interaction between the virus and the epithelial cell surface as quantified by the association constant, K a , which is now defined.

Expressing the fraction, F v , of viruses not bound by mucus and the fraction, F c , of host cells with bound virus in terms of the association constants, K mucin and K a .

Each binding process is represented by a dynamic equilibrium. Thus, within the given volume of the intestine, free virus (V free ) and host cells with no bound virus (C free ) are in dynamic equilibrium with cells with bound virus (C.V) as represented by:-

The association constant, K a , is expressed in terms of the concentrations (Gale, 2017) as:-

where the square brackets, [], represent the concentration in moles dm −3 (M). The term "in dynamic equilibrium" means the process is reversible (Handel et al., 2014) such that free virus binds to free host cells to form C.V with a rate, k on , and the C.V complexes then dissociate into C free and V free at a slower rate, k off , depending on the strength of binding. Thus the association constant, K a (and similarly K mucin ) may also be written in terms of the association/dissociation rates as:-

Visualising K a (or K mucin ) in terms of on/off rates may be easier conceptually and has implications when host or virus factors selectively change k on or k off (see below) thus affecting K a (or K mucin ) according to Eq. (6). As shown by Gale (2017) , the fraction, F c , of host cells with 1 . Fraction, F v , of virus not bound to mucin plotted as a function of the total mucin: total virus ratio. The virus challenge dose in the 0.314 dm 3 volume of intestine was fixed at 4.15 × 10 8 virus particles and the number of mucin molecules was increased from 10 3 to 4.15 × 10 12 molecules as represented by the symbols. Binding of all the virus is achieved below the horizontal dotted line which represents 1 unbound virus remaining in the intestine. Solid lines with symbols represent points calculated with difference equation approach (see text) with K mucin values of 10 22 (x), 10 20 (•), 10 18 (▲), 10 15 (■), 10 13 (Δ), 10 11.7 (♦) and 10 9 (□) (M −1 ). Dashed lines represent Eq. 11 assuming [Muc total ] ∼ [Muc free ] with K mucin values from left to right of 10 20 , 10 18 , 10 15 , 10 13 , 10 11.7 , 10 9 , 10 7 , and 10 5 (M −1 ). Eq. (11) fails for high K mucin values at mucin: virus ratios of < 1:1 (arrow). bound virus is given by:- ] c free Substituting [C.V] with Eq. (5) and rearranging gives F c in terms of the free virus concentration [V free ] and K a :-

Similarly, when the virus enters the host there will be a dynamic equilibrium between virus that is not bound to mucin and hence reaches the intestinal epithelium (V intestine ), free mucin (Muc free ) and virus bound to mucin (V.Muc).

The strength of the binding is reflected by the association constant, K mucin , between virus and mucin and is expressed as:-

The fraction of free virus (F v ) is given by:-

Replacing [V.Muc] with Eq. (9) and rearranging gives F v in terms of the free mucin concentration and K mucin :-

The objective is to construct a plot of F c as a function of V intestine as shown in Fig. 2 . Eq. (7) may be used with [V free ] representing [V intestine ] when the total number of virus particles, V intestine , greatly exceeds the number of host cells (C total ) such that [V free ] is relatively unaffected by virus binding and therefore [V free ] approximates [V intestine ]. This is also acceptable for low binding affinity viruses as in the species barrier model of Gale (2017) such that very little virus is bound even at high virus doses. However, in many natural infection processes (e.g. through drinking water), the host may be challenged by very low numbers of pathogen which bind with high affinity to host cells such that [V free ] is greatly diminished compared to [V intestine ] and tends to zero as all the virus is bound. The problem is that Eq. (7) cannot be expressed mathematically in terms of [V intestine ]. The solution adopted here to model F c in terms of [V intestine ] comprises three steps. The first step involves setting up a model for a host intestine so that the concentrations of virus and host cells may be defined in order to calculate K a using Eq. (5). In the second step, a difference equation approach is used to produce a range of [V free ], [C free ] and [C.V] combinations at six different total virus (V intestine ) doses. From these concentrations, K a values and F c values are calculated and are plotted in Fig. 3 . In the third step, for each of the six V intestine doses, the F c is read off Fig. 3 for given K a values. F c is then plotted against V intestine for each K a in Fig. 2 .

Developing a dose-response model based on K a and K mucin requires an estimation of the volume in dm 3 (i.e. litres) within which the challenge dose of pathogen has access to susceptible cells in the host. This is needed to convert particle numbers in moles into concentrations for use in Eq. (5). The volume into which the pathogen enters within the host is for example the lumen of the intestine or even a drop of body fluid (e.g. blood) on a mucosal surface in the case of EBOV. For the purpose of the model, a 100 cm length of host intestine with a radius of 1 cm is simulated. The total surface area is therefore 628.3 cm 2 and the volume inside the intestinal lumen is 0.314 dm 3 (1 dm 3 = 1000 cm 3 ). According to Rosen and Misfeldt (1980) the density of cells in dog kidney epithelia is 6.6 × 10 5 cells per cm 2 . The total number, C total , of epithelial cells over the 628.3 cm 2 surface of the model intestine is thus 4.15 × 10 8 , and the density of cells by volume is 1.32 × 10 9 per dm 3 . Dividing by the Avogadro number, L, of 6.02 × 10 23 particles per mole (Price and Dwek, 1979) gives a mole concentration by volume [C total ] of total host cells of 2.19 × 10 −15 M. It is reassuring to note that this is similar to the cell concentration of 4.1 × 10 −15 M reported for the canine kidney cells in the avian influenza virus binding experiments of Nunes-Correia et al. (1999) . Handel et al. (2014) in their simulation for influenza virus infection use a concentration which is ∼100-fold higher although they simply assumed a packed collection of cells each with a volume of 20 µm 3 . The model here therefore takes into account the large void volume of the intestine within which a faecal-oral pathogen is diluted.

Simulations were undertaken for six virus doses (V intestine ) from 1.0 × 10 3 to 4.15 × 10 11 virions in the model intestine ( Fig. 2) , representing virus: host cell ratios from 2.4 × 10 −6 :1 to 1000:1 and concentrations from 5.3 × 10 −21 M to 2.2 × 10 −12 M.

Difference equation approach to model F c against K a for each virus dose (Fig. 3) For low virus doses (i.e. V intestine < C total ), K a s were calculated using [C.V], [V free ] and [C free ] in Eq. (5) over the full range of virus binding i.e. from one bound virus to all V intestine viruses being bound. According to Eq. (4), each cell can only bind one virus, and the number of cells with bound virus therefore equals the number of viruses bound to cells which was calculated as:-

over the range of V free from 0 (all viruses bound) to V intestine (no viruses bound). For high virus doses (i.e. V intestine > C total ) the simulation was run for V free from 0 to C total (such that C.V is always positive) because the model in Eq. (4) assumes each cell can only bind one virus. For each C.V, the number of free cells, C free , was calculated as:-

Values for [C free ], [V free ] and [C.V] were calculated as C free , V free and C.V respectively, divided by the volume of the intestine (in dm 3 ) and L and then used to calculate K a in Eq. (5) over the range of C.Vs. For each virus challenge dose, values of F c are plotted as a function of K a in 

Microbial Risk Analysis 8 (2018) 1-13 Fig. 3 where F c is calculated as:-

c total (13) and C total , is constant at 4.15 × 10 8 cells (Table 1) .

The fraction of free virus, F v , represents the probability that virus is not bound to the mucin and in effect escapes the mucin barrier. The objective is to model F v as a function of the mucin to virus ratio over a range of K mucin values as shown in Fig. 1 . The simple approach to model F v is to use Eq. (11) with [Muc free ] representing the total concentration of mucin in the intestine, [Muc total ], which can be measured in a host experimentally. As discussed below, this fails at mucin: virus ratios of <1:1. Therefore a difference equation approach was used. For this, the challenge dose, V initial , in the host intestine was fixed at 4.15 × 10 8 virions and the fraction of virus not bound to mucin, F v was then calculated for ten values of Muc total ranging from 10 3 mucin molecules to 4.15 × 10 12 mucin molecules, representing mucin: virus ratios ranging from 2.4 × 10 −6 :1 to 10,000:1. This was done using the same stages as described above for virus binding to host cells for seven K mucin values ranging from 10 9 to 10 22 M −1 . Thus for the number of free mucin molecules, Muc free , ranging from 0 (i.e. all mucin molecules bound to virus) to Muc total (i.e. all mucin molecules free of virus), values of V.Muc and V intestine were calculated as:

By dividing by the volume of the intestine and L, the values of V.Muc, V intestine and Muc free were converted to corresponding concentrations, namely [V.Muc], [V intestine ] and [Muc free ], from which K mucin values were calculated using Eq. (9). For each K mucin value, F v was calculated as:

and a plot (not shown) of F v versus K mucin constructed in the same was as for virus binding to host cells in Fig. 3 . From that plot, values of F v for each of the ten Muc total s were read off for a given K mucin and plotted against the mucin molecule:virus ratio (i.e. Muc total :V initial ) in Fig. 1 .

Stochasticity in the challenge dose (V initial ) would be addressed in the exposure calculation and is outside the scope of this work. The mechanistic dose-response model developed here using the difference equation approach is not affected by stochasticity because the values of C.V and V intestine calculated in Eqs. (12) and (14) respectively are "given" integers, and thus F c and F v calculated by Eqs. (13) and (15) respectively are exact for each integer C.V and V intestine (C total and V initial being constant integers in the simulation). The probability of infection of the host according to Eq. (2) is calculated for each integer value of C.V from 0, 1, 2, … to C total or V intestine (depending on which is lower) and is not affected by stochasticity. The effect of stochasticity is considered here for the use of Eq. (7) to calculate F c and where C.V is a fraction.

The model assumes that the free pathogens and mucins are homogeneously distributed within the lumen of the intestine, such that the concentrations at equilibrium are constant along the 1 m length of the simulated intestine. The spatial heterogeneity of the pathogen in the lumen is not known and could vary depending on the pathogen distribution in the food, water or faecal/vomit contamination ingested by the host. For example, ingestion of a small amount of faeces laden with virus could give much higher virus concentrations at certain parts of the lumen, depending on the degree of mixing within the lumen. In contrast ingestion of a 0.314 dm 3 volume of water contaminated with pathogen could give a homogeneous (Poisson) distribution along the 1 m length. This is not considered further here. Spatial heterogeneity will exist in the mucin concentration because the mucus forms a layer lining the intestine wall (McGuckin et al., 2011) . This needs consideration in the further development of this mechanistic approach.

Here an intestine is simulated with an internal volume of 0.314 dm 3 and a total of 4.15 × 10 8 susceptible cells in the intestinal epithelium. In Fig. 1 , an oral challenge dose of 4.15 × 10 8 viruses is administered, and the fraction of these escaping the mucin barrier and reaching the epithelium is modelled. Fig. 3 shows the fraction of epithelium cells with bound virus as a function of K a for six doses of virus that have got through the mucin barrier ranging from 1000 virions to 4.15 × 10 11 virions. In Fig. 2 , the points from Fig. 3 are replotted in the form of a dose-response which relates the fraction of host cells with bound virus to the dose of virus that has got through the mucin barrier. These doseresponse relationships are presented for a range of K a values from 10 5 to 10 20 M −1 in Fig. 2 .

The fraction, F v , of virus escaping the mucus barrier is plotted as function of the mucin: virus ratio for a range of K mucin values from 10 9 to 10 22 (M −1 ) in Fig. 1 . The horizontal dotted line in Fig. 1 represents just one free virus remaining in the 0.314 dm 3 volume of the simulated intestine. At values of F v below this line there is < 1 free virus in the simulated intestine and in effect all of the 4.15 × 10 8 virions in the initial challenge dose (V initial ) are bound to mucin. Thus, the effectiveness of the mucin barrier can be assessed simply in terms of K mucin and the mucin: virus ratio required to bring F v to below this line in Fig. 1 . At the very high K mucin value of 10 22 M −1 all of the virus is bound as the mucin: virus ratio exceeds 1:1. However, at progressively lower K mucin values, less and less of the virus is bound at a given mucin: virus ratio. Thus even at K mucin values as high as 10 18 and 10 20 M −1 large numbers of viruses (20,330 and 180 respectively) are still free at mucin: virus ratios of 10:1. According to the model in Fig. 1 , in the 0.314 dm 3 volume of simulated intestine, large excesses of mucin over virus are needed to make a significant impact on the fraction of free virus at the lower K mucin values. For example, at K mucin values of 10 13 M −1 and 10 11.7 M −1 4% and 50% of the virus is free, respectively, at mucin: virus ratios of 1000:1. Thus mopping up virus is relatively inefficient and, except at very high K mucin values, large numbers of virus may break through. This reflects the dilution in the large volume of the simulated intestine. The main conclusion from Fig. 1 is that as the mucin: virus ratio increases from < 1:1 through 1:1 to > 1:1 (i.e. going from left to right along the x-axis) for high K mucin values ( > 10 15 M −1 ), then the fraction of free virus falls dramatically and non-linearly, with all of the virus being mopped up at K mucin of ∼10 22 M −1 .

As expected at mucin: virus ratios < 1:1, the fraction of free virus approaches 100%, even with very high K mucin values (Fig. 1) . This simply reflects the fact that there is not enough mucin capacity to mop up all the virus such that very high virus challenge doses overwhelm the mucin barrier. With very high K mucin values (10 22 M −1 ), a very slight excess of mucin over virus is sufficient to mop up all the virus. At intermediate K mucin values (10 18 -10 20 M −1 ) mopping up the last remaining viruses is less efficient and proportionately higher mucin: virus ratios are required at lower K mucin values.

3.1.2. Simplifying the approach: using Eq. (11) to model F v in MRA The total mucin: total virus ratio is also expressed as the concentration of total mucin, [Muc total ], on the x-axis scale of Fig. 1 . This is relative to the virus concentration in the intestine which is fixed at 2.2 × 10 −15 M. Thus 4.15 × 10 8 virus particles in a volume of 0.314 dm 3 on dividing by L represent a concentration of 2.2 × 10 −15 M. The dashed lines in Fig. 1 show F v as calculated by Eq. (11) for each K mucin value using [Muc total ] as an approximation for [Muc free ]. This is an appropriate approximation at high mucin to virus ratios. However, at mucin: virus ratios of < 1:1, [Muc free ] becomes much less than [Muc total ] as all the mucin is bound, particularly at high K mucin values, and Eq. (11) is not applicable. As an example, the arrow in Fig. 1 shows that Eq. (11) predicts that 4.4% of virus is free (i.e. 95.6% of virus is bound) when there is 10,000-fold more virus particles than mucin molecules. This is clearly not possible. At lower K mucin values, F v decreases linearly with increasing mucin: virus ratio and may be modelled by Eq. (11) in good agreement with F v calculated by the difference equation approach (symbols in Fig. 1 ). Thus Eq. (11) holds at low K mucin values or at high mucin: virus ratios (irrespective of K mucin ). This is important because high mucin: virus ratios might be expected in a natural infection situation even with the high virus challenge dose used in the simulation here. From the practical point of developing MRA methodology, applying Eq. (11) is easier than the complicated difference equation approach developed for the symbols in Fig. 1 . Thus understanding the limitations of Eq. (11) is important. In summary Eq. (11) fails at mucin: virus ratios of < 1:1 at the higher K mucin values, as represented by the arrow, but is generally applicable at lower K mucin values particularly at higher mucin: virus ratios. The results show that the value of K mucin is critical not only in determining whether Eq. (11) can be used in MRA but also in assessing how effective the mucin barrier is in mopping up viruses.

The fraction of host cells with bound virus increases linearly with the dose of virus in the simulated intestine for all K a values until at high virus doses the host cells become saturated (F c → 1) with virus ( Fig. 2) . At low K a values (<10 13 M −1 ) unrealistically high virus doses (>10 12 ) are required for saturation of the host cells. From Fig. 3 , F c increases linearly with K a at a given virus dose but, not surprisingly, is limited by the virus dose at V intestine : C total ratios of < 1:1. Thus, there are 4.15 × 10 8 cells in the simulated intestine, and for the virus doses of 10 3 and 10 6 virions, the maximum values achievable for F c are 2.4 × 10 −6 and 2.4 × 10 −3 respectively when all those virions are bound. At K a values of > 10 15 M −1 , the binding is so strong that all the virions in the dose are bound (Fig. 3) and F c reaches its plateau. At V intestine : C total ratios > 1 (i.e. the 4.15 × 10 10 and 4.15 × 10 11 doses in Fig. 3 representing V intestine : C total ratios of 100:1 and 1000:1, respectively) saturation of the host cells occurs at high K a values with progressively lower K a values required for saturation of the host cells as the virus dose increases. Thus increasing K a above certain values has no effect on F c either because all the viruses are bound at low virus doses (i.e. V intestine : C total ratios < 1) or because all the host cells are saturated at high virus doses (i.e. V intestine : C total ratios > 1). This is borne out in Fig. 2 which shows that for K a values > 10 15 M −1 , the dose-response curves are superimposed such that F c is limited by available dose and not by K a . The main conclusion of Figs 2 and 3 is that the value of K a over the range 10 5 to 10 15 M −1 is critical in affecting F c .

3.2.1. Simplifying the approach: using Eq. (7) to model F c in MRA

The total virus dose in the intestine (V intestine ) may be approximated to V free , converted to a concentration and used as [V free ] in Eq. (7) to calculate F c as an alternative to the difference equation approach used to construct Fig. 2 . However, this simplification fails at K a values greater than 10 15 M −1 (results not shown) for which Eq. (7) overestimates F c by orders of magnitude at low virus doses. The results show that Eq. (7) is appropriate to calculate F c up to K a values of at least 10 13 M −1 irrespective of dose.

The application of the model is demonstrated in Table 2 for four scenarios representing different combinations of initial challenge dose and affinity of the virus for the cell (as determined by K a ). Thus the K a is 10 10 M −1 for the low affinity binding virus and 10 13 M −1 for the high affinity binding virus. These broadly reflect those measured experimentally (Nunes-Correia et al., 1999) for low binding and high affinity binding sites for influenza A virus H5N1 binding to canine kidney cells (Table 3) . Also as discussed below, this difference of 1000-fold in K a could reflect the result of a single amino acid change in the GP or Cr molecule affecting a salt bridge at the GP/Cr interface. For the purpose of the demonstration, p cell is assumed to be 0.1, i.e. a cell with bound virus has a 10% chance of successful infection. For these scenarios, the predicted probability of the host being infected, p host , ranges from 4.4 × 10 −5 to 0.988. F v is constant at 0.19 (Table 2 ) and is calculated using Eq. (11) with a K mucin of 10 9 M −1 (at which Eq. (11) is appropriate) and a [Muc free ] of 4.25 × 10 −9 M. This value of [Muc free ] is calculated using a mucin mass concentration of 1.7 mg/ml for saliva (Kejriwal et al., 2014) , a dilution factor of 100-fold in the food or water matrix and a mucin protein molecular weight of 4000,000 Daltons (Kesimer and Sheehan 2012) . It is solely calculated for demonstration purposes in Table 2 in the absence of published data. F c in Table 2 varies for each scenario and is calculated using Eq. (7) with [V free ] calculated from V intestine (in the 0.314 dm 3 volume of the simulated intestine) and L. The values of K a used in these scenarios are low enough such that Eq. (7) is applicable (see above) as can be seen for the K a = 10 13 M −1 line from the difference equation approach in Fig. 2 where F c ∼ 1.0 × 10 −7 for a V intestine of 1904 virions in agreement with Table 2 .

The approach using F c from Eq. (7) predicts fractions of a C.V (Table 2) for both low dose scenarios and also for the high dose, low affinity scenario. In reality CV must be an integer as in the difference equation approach. The issue of stochasticity arises in the model Table 2 Demonstration of the application of the mechanistic dose-response model: Predicting the probability of infection of the host (p host ) from the initial challenge dose (V initial ) for a low and a high affinity binding virus. Table 2 when C.V is a fraction. To investigate the effect of stochasticity, the mechanistic model developed in Table 2 is used to determine the infectious dose 50% (ID 50 ), i.e. the value of V initial for which p host = 0.5. It was found that for the high affinity virus (K a = 10 13 M −1 ), the ID 50 is 1574 viruses and for the low affinity virus (K a = 10 10 M −1 ) the ID 50 is 1574,000 viruses (Table 4 ). The C.V value for the ID 50 is 6.6 and, being much greater than 1, is in the range where stochasticity is less of an issue. The classic dose response model for infection of a host is written as:-

where p 1 is the risk of infection from ingestion of a single virion by the host. By rearranging Eq. (16) and setting V initial = ID 50 and p host = 0.5, p 1 is calculated as 4.4 × 10 −4 and 4.4 × 10 −7 for the high affinity and low affinity viruses respectively. These values may be used directly in the conventional dose-response model in the form of Eq. (16). Furthermore, setting V initial = 1 in the mechanistic model in Table 4 predicts the same probability values of 4.4 × 10 −4 and 4.4 × 10 −7 for the high affinity and low affinity viruses respectively suggesting that stochasticity is not a problem as expected for dose-response models which are linear at low doses.

The values of p host are also calculated in Table 2 by using p 1 (obtained from the mechanistic model as described above) directly in Eq. (16) to estimate the risk from the initial challenge dose (V initial ). The results are identical with those predicted by the mechanistic method. Large and negative (see below) hence lowering magnitude of K a K a Calculated from K d , n and ΔS a using Eq. (17) *For n = 3 and K d = 10 −4 M, K a = 10 12 M −1 . *For n = 1 and K d = 10 −12 M, K a = 10 12 M −1 . *assuming ΔS a = 0 J/mol/K Approach 3: Calculation of K a from enthalpy and entropy terms Enthalpy term, ΔH a Favourable interactions (e.g. formation of salt bridges) between amino acid residues at GP/Cr contact interface and good spatial fits give a large negative value driving virus binding. Limited by lack of specific data for GP/Cr contacts or for virus/host cell binding −56.5 kJ/mol for antibody binding to its antigen (Bostrom et al., 2011) . −4958 kJ/mol for VSV binding to PL bilayers (Carneiro et al., 2002) Entropy term, ΔS a Component entropy terms ΔS solvent Likely to be positive as disordering and hence entropy of water solvent molecules displaced from GP/Cr contact surfaces during binding may increase +401 J/mol/K for antibody binding to its antigen (Bostrom et al., 2011) ΔS conf Negative due to reduction in conformational mobility. Estimated to be −6.1 J/mol/K per amino acid for ordering of disordered regions of proteins (Rajasekaran et al., 2016) −301 J/mol/K for antibody binding to its antigen (Bostrom et al., 2011) ΔS rt Negative for all interactions when a particle is immobilised on a surface.

−209 J/mol/K for a pentapeptide binding to a lipid membrane (Ben-Tal et al., 2000) . −33.5 J/mol/K for antibody binding to its antigen (Bostrom et al., 2011) ΔS mem Negative giving a repulsive force pushing virus away from host cell (Sharma, 2013) No data

Overall 1.0 × 10 9 1.0 × 10 9 1.0 × 10 9 1.0 × 10 9 [Muc free ] (M) 4.25 × 10 −9 4.25 × 10 −9 4.25 × 10 −9 4.25 × 10 −9 F v (Eq. (11) This not only provides further evidence that stochasticity is not an issue but also demonstrates how the output from the mechanistic model can be applied directly to conventional dose-response models.

Three approaches for parameterising K a are set out in Table 3 . In a few cases, the K a is determined experimentally by directly measuring virus binding to cells (Table 3) . Approach 2 developed here is to estimate K a from published K d values which are routinely measured experimentally. Thus, the magnitude of K a for binding of a virus to its host cell is determined by the strength of the interaction(s) between viral surface components, typically the viral glycoprotein (GP) in the case of enveloped viruses such as EBOV, and the receptors (Cr), e.g. T-cell immunoglobulin and mucin domain protein 1 (TIM-1) for EBOV, on the human host cell surface (Yuan et al., 2015) . Biochemists quantify the binding affinity between molecules in terms of the dissociation constant (Price and Dwek, 1979) : ] d for the reversible dissociation process given by:-

The magnitude of K d in units of mol/dm 3 (M) may be determined experimentally between purified parts of the virus GP and the host Cr using surface plasmon resonance (SPR) in which one protein "partner" is immobilized to a chip surface and changes in refractive index are used to measure binding of the other "partner" which is free in solution. Thus, Yuan et al. (2015) immobilized EBOV-GP to a chip and used SPR to measure a K d of 2.67 × 10 −5 (M) for binding of soluble human TIM-1 from solution. EBOV entry involves a second GP/Cr binding step within the endosome in which the GP binds to the host Niemann-Pick C1 (NPC1) protein. Using SPR, Wang et al. (2016) reported a K d of 1.58 × 10 −4 (M) for EBOV GP binding to human NPC1. These binding affinities for EBOV GP are much weaker than that for MERS-CoV binding to its cellular receptor CD26 for which the K d was 1.67 × 10 −8 (M) as measured by SPR (Lu et al., 2013) . Raman et al. (2014) summarise K d s for influenza virus HA binding to host cell glycans on human tracheal and alveolar sections. Some HAs bind to human receptors with K d s in the 10 −12 M range, while others show K d s of ∼10 −9 M. Gambaryan et al. (2005) present K d s for binding of H1 and H3 influenza viruses to glycans, typically in the range of 10 -100 × 10 −9 M.

For a single GP/Cr interaction, K a is the reciprocal of K d . However, the reciprocal K d values measured by SPR for the GP/Cr interaction cannot directly be used as the K a values in Figs. 2 and 3. This is because K d as measured by SPR does not take into account the number of GP/Cr contacts per virus/cell interaction and also does not allow for any changes in the entropy (S) on the binding and immobilization of a whole virus particle to a cell (discussed below). For example, Beniac et al. (2012) calculated that an EBOV virion filament of 982 nm in length would have about 1888 copies of the GP spike protein and could therefore make multiple contacts with Cr molecules on the host cell surface. The change in Gibbs free energy (ΔG d ) for dissociation of one mole of GP/Cr contacts is related to K d (Price and Dwek, 1979; Kastrits and Bonvin, 2013) 

where T is the temperature and R is the ideal gas constant (8.31 J/mol/ K (Price and Dwek 1979)). Since the Gibbs free energy (G) is a state function in thermodynamics, the overall change in G for dissociation of n moles of GP/Cr contacts, is given by

Since the change in Gibbs free energy (ΔG a ) for association of one mole of virus with one mole is cells is related to K a by = − G R T l n K Δ a a (Gale, 2017) and the change in Gibbs free energy for association of n mole of GP/Cr contacts, = − G n G Δ Δ a d (Kastrits and Bonvin, 2013 ) then = K .

a K 1 d n Taking into account the change in entropy on whole virus binding, ΔS a , (discussed below) K a may be expressed as:-

The value of G is affected by temperature and pressure, and for this reason G is used by biochemists. Thus providing the temperature and pressure are constant, as assumed here for virus in the host intestine, then any changes in G relate only to those changes in energy within the system of interest, namely from the molecular interactions between virus and host during infection within the simulated intestine.

Approach 3 in Table 3 is to calculate the association constant K a through the changes in two thermodynamic parameters, namely enthalpy (H) and entropy (S) on binding. Thus K a , is related to ΔG a for association of the virus with the cell (Gale, 2017; Kastrits and Bonvin, 2013) according to:

which on rearranging gives

where ΔH a and ΔS a are the changes in enthalpy and entropy, respectively, of the virus/host cell system on association (Carneiro et al., 2002; Gale, 2017) . Therefore in principle knowing ΔH a and ΔS a would enable calculation of K a and hence F c for a given dose of virus from Fig. 2 . Bostrom et al. (2011) demonstrated how the binding affinity of an antibody could be broken down into the enthalpy and entropy terms. How this approach could be applied to a virus during infection with the aim of calibrating dose-response models is summarized as Approach 3 in Table 3 . To the author's knowledge there are no data for ΔH a and ΔS a for viruses binding to host cells. However, Carneiro et al. (2002) measured the forces between vesicular stomatitis virus (VSV) and an artificial phospholipid (PL) bilayer (as opposed to a host cell) and obtained values for ΔH a and ΔS a of −4958 kJ/mol and = −16,062 J/ mol/K respectively. Carneiro et al. (2002) Approaches 2 and 3 in Table 3 are dependent on estimating ΔS a . As shown by Carneiro et al. (2002) for VSV binding to PL bilayers, the decrease in entropy is huge (Table 3) , demonstrating the importance of understanding ΔS a in estimating K a . Unlike ΔH a which is based on molecular contacts at the binding faces, ΔS a involves changes in order and mobility and is difficult to visualise, but may be broken down into a number of components which act additively (Bostrom et al., 2011) . Thus

where ΔS solvent is the change in entropy of the water solvent molecules, ΔS conf is the change in the internal conformational freedom of the proteins, ΔS rt is the change in rotational and translational freedom of the virus, and ΔS mem is an entropic pressure associated with bringing two membranes close together, as for example, when the virus envelope approaches the host cell membrane prior to fusion (Sharma, 2013) . The likely contributions from the four entropy component terms are summarized in Table 3 .

Many ligand binding proteins have intrinsically disordered regions (IDRs) which undergo a disorder-to-order transition on or near the interface on binding the ligand (Fong et al., 2009) decreasing the entropy such that ΔS conf is negative (Rajasekaran et al., 2016) . Viral proteins are rich in intrinsic disorder (Dolan et al., 2015) and intrinsically disordered proteins serve as host cell receptors for viruses. An example is the ephrin receptor ligand binding domain (Fong et al., 2009 ) which also serves as receptor for Hendra virus (HeV) and NiV (Xu et al., 2012) . Thus the unbound ephrin receptor contains partially disordered loops. In the complex (bound to ephrin) these loops are ordered to form the ligand-binding channel (Fong et al., 2009) . This raises the question of whether the ephrin receptor undergoes a disorder-to-order transition on HeV/NiV binding. Interestingly Xu et al. (2012) show from the X-ray crystal structure that the binding of HeV G protein involves the movement of a tryptophan "latch" on the ephrin-B2 receptor. There would be a change in the conformational entropy ΔS conf associated with this during formation of the HeV G protein/ephrin-B2 receptor complex.

According to Eq. (17), increasing the number of GP/Cr contacts during virus binding increases K a and hence the infectivity according to Fig. 3 . Counterintuitively, in the case of EBOV GP pseudoviruses, increasing the surface density of GP actually decreases the infectivity by about 10-fold, perhaps reflecting steric hindrance from tightly packed GP proteins (Mohan et al., 2015) blocking a conformational change that gives an increase in ΔS conf required for binding of GP to TIM-1 (Gale, 2017) . This is consistent with the observation that EBOV GPs are well separated in space on the EBOV filament surface (Beniac et al., 2012) thus allowing plenty of space for conformational changes without steric hindrance. A demonstration of how changes in ΔS conf could explain the 10-fold increase in infectivity reported by Mohan et al. (2015) on decreasing the GP density may be explored with Eq. (19) . Thus increasing ΔS a by 20 J/mol/K (irrespective of the values of ΔH a and T) increases K a by 11-fold. A decrease in conformational entropy (ΔS conf ) due to steric hindrance of 20 J/mol/K represents the ordering of just four amino acid residues on the basis of the −6.1 J/ mol/K per residue proposed by Rajasekaran et al. (2016) for disordered proteins. Therefore blocking the disordering of just four amino acids in the EBOV GP could explain the 10-fold decrease in infectivity of EBOV GP pseudoviruses with high GP densities. Booth et al. (2013) show that filovirus filaments are very flexible, more flexible than filamentous paramyxoviruses and much more flexible than rhabdoviruses. Thus a flexible filament, making multiple GP/ Cr contacts, can adopt many more conformations in 2D-space when bound to a host cell surface than a rigid rod of the same length. A bound filament will therefore have a higher entropy than a stiff rod, and will have a higher K a . A flexible filament can also test out multiple GP/Cr contacts, thus maximising contacts and making ΔH a more negative in magnitude which increases K a according to Eq. (19). Indeed Booth et al. (2013) suggest that the extreme aspect ratio of filaments may be an adaptation that enhances cellular attachment.

The association of two species to form a bound complex, e.g. the binding of a ligand to a protein or the adsorption of a peptide on a lipid membrane, always involves an entropy loss (Ben-Tal et al., 2000) . This no doubt applies to the binding of viruses to cells. Consideration of ΔS rt may be of particular importance for binding of filoviruses (Gale, 2017) which comprise repeating modular units linked together into single very long filaments (Beniac et al., 2012; Booth et al., 2013) . Thus Gale (2017) argued that the prior immobilisation of multiple virus units through linking together into a polyploid filament enhanced cell binding compared to that of single virus units in the case of filoviruses through a less unfavourable ΔS rt term. Furthermore for this reason, natural polyploid filovirus filaments may bind more strongly to cells than suggested by results from experiments to determine filovirus infectivity using EBOV GP-expressing pseudoviruses, which are spherical and single.

4.3. Using enthalpy to relate changes in amino acid sequence at the binding faces of the virus GP and host receptor protein to a change in K a While lack of data on ΔH a limits the use of Approach 3 in Table 3 to determine K a , Eq. (19) may be applied to determine the impact of amino acid changes in GP and Cr on K a and hence link genetic sequencing data to the risk of infection. The ultimate aim would be to predict how such sequence changes affect infectivity, host range and jumping the species barrier from the perspective of the dose-response. This could include assessing the relative risk of novel strains of virus with mutations in the GP and also assessing the risk of a "standard" virus jumping the species barrier into a novel host which may have amino acid differences in its Cr relative to the "standard" host. The starting point is having information on the infectivity of the "standard" virus in the "standard" host and also crystal structure data of the "standard" virus GP bound to the "standard" host Cr. Crystal structure data are available for a number of viral GPs docked to their human host cell Cr at atomic detail including EBOV and MERS-CoV (Zhao et al., 2016; Wang et al., 2016; Lu et al., 2013) . Knowing the crystal structure of the GP/Cr protein complex assists in understanding how changes in amino acids at the binding interface of GP and Cr affect ΔH a and hence K a through Eq. (19). Thus although ΔH a itself may not be known, it may be possible to predict the change in ΔH a (i.e. ΔΔH a ) for an amino acid substitution from basic biophysics knowledge of the energies of the intermolecular forces that hold proteins together. These are typically salt bridges and hydrogen bonds as shown for MERS-CoV bound to its Cr (Lu et al., 2013) . An example of how this could be applied is demonstrated in Table 5 for changing amino acids involved in salt bridges. In a salt bridge a negatively charged amino acid residue on one protein interacts electrostatically with a positively charged residue on the other protein resulting in a strong attraction. Salt bridges, e.g. between histidine 30 (positively charged) and aspartate (Asp) 70 (negatively charged) in bacteriophage T4 lysozyme contribute −11 to −21 kJ/mol to ΔG (Anderson et al., 1990; Dong and Zhou, 2002) . For the purpose of the demonstration in Table 5 it is assumed that the ΔH a for a salt bridge formation is −17.8 kJ/mol as this gives a 1000-fold change in K a (Price and Dwek 1979) for each salt bridge removed or added through mutation. Proximity of two residues of the same charge results in electrostatic repulsion as in Scenarios A and B which represent viruses with very weak affinities for the host. Scenarios D and E represent viruses which have adapted to the host with hugely increased affinities. Scenarios A and E are only two mutations away from each other. Thus changing two positively charged amino acids (Scenario A) into negatively charged amino acids (Scenario E) could increase K a by 10 12 -fold.

Amino acid changes in the EBOV GP affect its host specificity. Thus, EBOV Makona in the 2013 West Africa outbreak adapted to humans (and in doing so became less infectious to bats) through substituting alanine (A) with valine (V) at residue 82 of the GP (Diehl et al., 2016; Urbanowicz et al., 2016) . This is referred to as the A82V substitution. However, the changes in infectivity to humans (as measured by EBOV GP pseudoviruses infecting human cell lines) appear to be relatively small and in the range of 2-fold to 4-fold. A 4-fold increase in infectivity due to a 4-fold increase in F c in Fig. 3 would reflect a 4-fold increase in K a , and a change in ΔG a according to Eq. (18) of −3.6 kJ/mol. This would probably reflect changes in ΔH a (and not the T.ΔS a term) since residue 82 on the EBOV GP is between residues 80 and 83 which make multiple atom contacts directly with six surface residues on the NPC1 protein (Wang et al., 2016) . Thus, the A82V substitution in the GP may change ΔH a by ∼−3.6 kJ/mol on the basis of measured changes in infectivity. This relatively small change (compared to the −11 to −21 kJ/mol for a salt bridge) is consistent with the chemical similarity of alanine and valine.

In the human NPC1 protein (Cr), an Asp at residue 502 protrudes from the surface and contacts the EBOV GP in the docked complex (Zhao et al., 2016) . The natural presence of phenylalanine (Phe) at residue 502 (instead of Asp) in the NPC1 of the African Straw-coloured fruit bat (Eidolon helvum) appears to protect this species from EBOV (Ng et al., 2015) . Indeed, replacing Phe at residue 502 of E. helvum NPC1 with Asp completely restored its binding to EBOV GP (Ng et al., 2015) . From the X-ray structure, the presence of Phe at residue 502 of the NPC1 in E. helvum would cause severe clashes on binding EBOV GP (Zhao et al., 2016) such that ΔH a in the E. helvum NPC1/EBOV GP complex would be significantly less negative than that for binding to human NPC1 and perhaps even positive (reflecting a repulsion). Indeed, determining ΔΔH a would enable the effect of the Asp to Phe substitution at residue 502 on K a and hence on the infectivity of EBOV to E. helvum to be assessed through Eq. (19) as in Table 5 . Hoffmann et al. (2016) developed VSV pseudoviruses with filovirus GPs expressed on their surfaces to test the efficiency of GP-mediated cell entry into cell lines of different bat species. Hoffmann et al. (2016) demonstrated that the efficiency of entry of EBOV-GP VSV pseudovirus into E. helvum cell lines was markedly reduced compared to that with GPs from other filoviruses and at standard virus levels no infection was detected. However, at high levels of (i.e. undiluted) virus, EBOV-GP VSV pseudovirus did show significantly increased infection compared to the negative controls. Thus EBOV GP is capable of mediating entry into E. helvum cells, albeit with low efficiency. This is entirely consistent with the dose-response model simulated in Fig. 2 which predicts for low K a s (10 5 -10 7 M −1 ) that very small fractions (10 −7 to 10 −5 ) of the host cells have bound virus at very high virus doses, i.e. 10 11 to 10 12 . Thus some infection would be expected in E. helvum on the basis of Eqs. (2) and (3) and the probability of infection which, although low at low K a values, would never be zero because there is no threshold K a below which binding does not occur (Fig. 3) . Supporting this, Hayman et al. (2010) reported EBOV antibodies in one of 256 E. helvum bats tested in Ghana and suggested this resulted from EBOV infection.

Values for K mucin may be derived from published data on the strength of interactions between lectins and glycans. Lectins are proteins which bind selective glycan groups (Taylor and Drickamer, 2006) . Viruses such as influenza virus, NoV and rotavirus behave as lectins by binding selectively to glycans. Indeed, K mucin is related to the number of lectin/glycan interactions and their respective K d s in the same way as K a according to Eq. (17). Dam and Brewer (2010) report K d s of 2.0 × 10 −10 M for the lectin soy bean agglutinin binding to porcine submaxillary mucin which has multiple GalNAc sugars to bind. Similarly Vataira macrocarpa lectin has a K d of 1.0 × 10 −10 M with porcine submaxillary mucin. Acting singly (i.e. using n = 1 in Eq. (17)), these K d s would translate into K mucin values of ∼10 10 M −1 at which very high excesses of mucin would be needed to achieve removal of the virus according to Fig. 1 . There are two mechanisms by which the magnitude of K mucin could be increased:-1. Through multiple binding interactions; and 2. Through irreversible binding.

The effect of multiple contacts on the strength of binding has been shown for binding of the mannose binding protein (MBP) to carbohydrate structures on the surfaces of pathogens. Each carbohydrate-recognition domain (CRD) of the MBP interacts only with the terminal sugar residue in an oligosaccharide chain (Taylor and Drickamer, 2006) . The K d for interaction with a high mannose oligosaccharide is ∼10 −3 M, i.e. low affinity. High-affinity binding of MBP requires interaction of multiple CRDs with multiple terminal mannose residues. The trimeric structure of MBP presents a cluster of CRDs for interaction with appropriately spaced terminal mannose residues on the pathogen surface. Thus the arrays of terminal sugar residues on the surfaces of microorganisms can interact with multiple sites Table 5 Theoretical consideration of how changes in ΔH a (ΔΔH a ) through mutations affecting two amino acid residues involved in salt bridges at the contact interface between GP and Cr could affect the binding affinity K a at 310 K (37°C).

Effect of mutation on the number of charged amino acid residues opposite each other at the contact surface of GP and Cr Representation (+, positive amino acid residue; −, negative amino acid residue; 0, electrostatically neutral amino acid residue)

ΔΔH a (kJ/mol) relative to Scenario C. Calculated assuming one salt bridge contributes 17.8 kJ/mol (Anderson et al., 1990) Effect simultaneously. As shown in Eq. (17), a three way interaction involving three binding sites with K d s of 1.0 × 10 −3 M can result in an overall K a of up to 1.0 × 10 9 M −1 for a multivalent ligand (i.e. pathogen surface) with appropriately spaced terminal sugar residues (Taylor and Drickamer, 2006) . In the case of influenza virus A, the binding site of each HA polypeptide is relatively shallow and interacts primarily with the terminal sialic acid residues linked to galactose (Taylor and Drickamer, 2006) . The affinity for monomeric sialosides is weak (K d ∼10 −3 M), but binding to cell surfaces is enhanced by the simultaneous interaction of multiple HA-binding sites with multiple sialic acid residues on the target host cell (Taylor and Drickamer, 2006) . The cumulative effect of n binding sites each with the same K d is given by the n th power (Eq. (17)). Thus seven interactions with K d ∼10 −3 M, for example, would give a K a ∼10 21 M −1 . It is concluded that mucins and MBP PRRs of the innate immune system could bind virus with sufficient affinity such that slight mucin excesses could remove all the virus (Fig. 1) . Furthermore, K mucin could become higher if the virus were irreversibly bound for example by being "folded in" to the inside of mucous droplets such that it can no longer exchange with free virus on the outside. In effect k off would tend to 0 in Eq. (6) and hence K mucin would tend to infinity. It should be noted that the magnitude of K d (and hence K a and K mucin ) is constant for a given molecular interaction at a given temperature. However, the magnitude of K mucin may change during the infection process through both host mechanisms and virus mechanisms as is now discussed.

Mucin glycosylation changes during infection such that mucins isolated from rotavirus-infected mice at 4 days post infection were more potent at inhibiting rotavirus infection than mucins from control mice (Boshuizen et al., 2005) . Interestingly there are also age-dependent differences in mucin quantities, composition, and/or structure which alter the antiviral capabilities of the small intestine mucins (Boshuizen et al., 2005) . Furthermore, mucin production by the host increases during infection by rotavirus with mucin-coding mRNA levels peaking at 1 day post infection (Boshuizen et al., 2005) . Thus both the mucin: virus ratio and the magnitude of K mucin could change during progression of the infection, hence affecting F v in Fig. 1. 

There are viral mechanisms that remove the virus from the mucin so increasing the concentration of free virus. For example in the case of influenza virus, the neuraminidase removes sialic acids from glycans, which enables virus particles to be removed from the cell surface after assembly and from decoy receptors e.g. in mucus (Guo et al., 2017) . This has two effects on virus binding in Fig. 1 . First it increases the rate of removal of the virus (k off in Eq. (6)) and hence decreases K mucin . Second it decreases the concentration of mucin thus decreasing the mucin: virus ratio. From Fig. 1 both these act synergistically to increase the fraction of free virus.

In the case of influenza viruses, the HA protein binds to sialoside receptors on the host cell surface, preferentially binding to sialic acids linked to a penultimate galactose (Guo et al., 2017) . The balance between activities of HA and neuraminidase proteins has a critical role in optimal viral fitness, tropism and transmission (Guo et al., 2017) . The opposing effects of HA and neuraminidase in influenza A virus infectivity could be modelled through their effect on K mucin (through k on and k off in Eq. (6)) and the mucin: virus ratio in Fig. 1 . Handel et al. (2014) use differential equations to model how sticky an influenza virus should be to maximize fitness, with stickiness representing the balance between attachment and detachment. Shanker et al. (2011) proposed that local flexibility in part of the NoV surface protein could allow the virus to disassociate from salivary mucin-linked HBGA in the changing microenvironment (pH for example) during its passage through the GI tract to subsequently associate with HBGAs linked to intestinal epithelial cells. In effect the k off rates increase in Eq. (6) such that K mucin varies in different parts of the host.

This is a concept paper which presents a generic approach to use data from biochemistry and molecular biology to parameterize doseresponse models for MRA through thermodynamic equations. In the model developed here a host intestine is simulated with 4.15 × 10 8 cells in a volume of 0.314 dm 3 . The initial infection process is broken down into two stages, namely escape of the virus from the innate host defense barriers (Fig. 1 ) and the subsequent binding of any remaining virus to its specific receptor on the host cell (Fig. 2) . The two parameters, namely F v and F c , which quantify these stages represent probabilities which together with p cell can be used with Eqs. (1)-(3) to give a complete dose-response model which calculates the risk of infection of the host from a given challenge dose (V initial ). (Although V intestine from Eq. (1) does not appear in Eqs.

(2) or (3), it is used in Fig. 2 to estimate F c for Eq. (3)). The difference equation approach developed here is tedious to apply to MRA and applying Eq. (7) and Eq. (11) would greatly simplify the calculation of F c and F v , respectively for MRA purposes. However, using Eq. (7) for F c fails at low doses of a virus which has a high binding affinity for the host cells (K a > 10 15 M −1 ) and the difference equation approach has to be used as in Fig. 2 . Using Eq. (11) for F v is appropriate for MRA if the mucin concentration exceeds the virus concentration in the host by a factor of > 10 or if K mucin < 10 13 M −1 (Fig. 1) .

The mechanistic approach developed here may be used to determine the ID 50 (see Table 4 ) from which it is easy to calculate p 1 , the risk to the host from ingestion of a dose of one pathogen. The parameter p 1 may then be used directly in conventional dose-response models (Eq. (16)) thus linking the application of the mechanistic model developed here to MRA. The work here appears to demonstrate that stochasticity in the mechanistic model is not an issue. If stochasticity issues were to arise for low doses of very high affinity pathogens (i.e. those with very high K a ), the approach should be to use the difference equation approach to determine the ID 50 from which p 1 can then be calculated and used directly in Eq. 16. Thus, depending of course on the value of p cell , C.V is much greater than 1 for the ID 50 (Table 4 ) and stochasticity issues are minimised.

Although more information on the concentrations of mucin proteins in the saliva and intestine is needed, lack of data on the thermodynamic parameters is the main limiting factor. Approach 3 (Table 3 ) which uses Eq. (19) to calculate K a is limited by the current lack of data for ΔH a and ΔS a for the virus/host cell interaction and Approach 2 using published K d data should therefore be pursued in the absence of experimental K a data from Approach 1. While data are available for K d for GP/Cr binding for several viruses, Approach 2 using Eq. (17) to estimate K a is also limited by lack of information on ΔS a for binding of the whole virus to cells. This is important because the magnitude of ΔS a for immobilization of a whole virus is likely to be huge as demonstrated for VSV binding to artificial PL bilayers (Table 3) . Lack of information on ΔS a is therefore a major data gap, and furthermore may also have wider implications in affecting our ability to interpret measured K d values in terms of the actual infectivity of the virus. Thus it is the K a as determined by Eq. (17) taking into account ΔS a for whole virus binding which defines infectivity (see results from Table 2 ) and not the K d alone. This is because ΔS a for binding of the whole virus to cells will be much greater than the ΔS a for binding of a soluble protein fragment as in K d determinations by SPR. Indeed the ΔS a for binding of VSV is a huge −16,062 J/mol/K compared to the ΔS rt and ΔS conf terms for binding of an antibody to its antigen (Table 3) which is comparable to GP binding to its Cr in terms of molecular sizes.

The model developed here based on Eq. (4) does not allow for multiple virus particles to bind to a single host cell. However, the cell membrane of the host cell typically contains many copies of Cr and in theory each host cell could therefore bind multiple copies of the virus. Furthermore, the virus particles themselves could be ingested as a clump. Indeed in the case of EBOV, many genome copies may be linked together into long polyploid filaments (Beniac et al., 2012) which could affect the thermodynamics of binding (Gale 2017) . Eq. (4) could be modified to accommodate multiple viruses binding to a single host cell (as described for ligands binding to a protein by Price and Dwek (1979) ) if the number of Crs per host cell is known. It should be stressed that homogeneity in both the mucin and pathogen is assumed here for simplicity. In further developing this mechanistic model, data would be needed not only on the heterogeneity of the mucin concentration but also on the statistical distribution for the number of viruses bound per cell. For example the distribution could be Poisson such that for a ratio of 1 virus bound per host cell (representing a high V intestine ), some host cells have zero, most have one while a few have two, three or even four viruses bound. Alternatively the distribution could be over-dispersed, such that a few host cells have thousands of bound virus while most have none. Clearly, over-dispersion would decrease C.V compared to the Poisson distribution. In the model presented here for demonstrating proof of principle, the modelling of F c as function of V intestine assumes each host cell binds just one virus through Eq. (4). This is appropriate for two reasons. First, exposure to faecal/oral pathogens through routes such as water may involve very low numbers of pathogen per person (see Gale 2017) , such that it would be unlikely that more than one pathogen would bind to the same host cell. Second, it maximises C.V and hence p host . Thus, the binding of more than one virus to a host cell may be waste of virus resource because C.V in Eq. 2 is not maximised. Binding of two viruses to the same cell will not affect p cell , unless there is co-operation between the two viruses in some way, such that one facilitates infection by the other. In this sense, the value of p host predicted through the mechanistic dose-response here is worst case. It should be noted that Gale (2017) proposed that formation of polyploid filaments in the case of EBOV did indeed enhance cell binding by optimising ΔS a , in effect representing a co-operation between viral particles in the infection process. This demonstrates the importance of not only considering the statistical distribution aspects of virus clumps but also the thermodynamic implications on their binding.

As shown in Fig. 1 , the probability of the virus escaping the mucin barrier (as represented by F v ) is controlled by the mucin: virus ratio and the mucin/virus binding affinity as represented by K mucin . The range for which K mucin is biologically significant is < 10 22 (M −1 ); 10 22 being the K mucin value at which there is no free virus at mucin: virus ratios > 1:1 according to the simulation in Fig. 1 . Values for K mucin could be high due to multiple contacts with repeating units and "folding in" of bound virus into the interior of the mucus. Reading the x-axis from right to left in Fig. 1 suggests a threshold effect for virus dose, as the binding capacity of the mucin is exceeded at high virus doses. This is not considered further here, but is of interest for the development of MRA which generally assumes there is no threshold dose. The approach developed here in Fig. 1 for mucins could also be applied to modelling the probability of the virus being inactivated by other components of the host innate immune system such as the PRRs, which include the MBP, which recognize repeating units on the pathogen surface. Once bound to the MBP, the virus would be taken up (phagocytosis) through the complement system by macrophages and destroyed (Taylor and Drickamer, 2006) .

The probability of a host cell having bound virus (as represented by F c ) increases linearly with dose (Fig. 2) . The biologically significant range for K a is 〈10 15 (M −1 ) within which F c increases linearly with increasing K a (Fig. 3) . K d values measured by SPR are in the 10 −9 M-10 −12 M range for GP/Cr interactions for MERS-CoV and influenza virus suggesting very strong binding (Lu et al., 2013; Raman et al., 2014) . Even for EBOV GP with K d s in the 10 −4 to 10 −5 M range (Yuan et al., 2015; Wang et al., 2016) , high K a values could be achieved through multiple contacts (Eq. (17)) although this may be offset by the ΔS a term (as discussed above). Increasing the K a above 10 15 M −1 does not further increase the fraction (F c ) of host cells with bound virus (Fig. 3) such that F c versus virus dose curves are superimposed in Fig. 2 at K a 〉 10 15 M −1 . At such high K a s, receptor binding is not likely to be rate-limiting in the infection process. Thus Xu et al. (2012) found that the stability of the HeV-G/ephrin-B2 association does not strongly correlate with the efficiency of viral entry, suggesting that, for ephrin-B2-expressing cells, viral attachment is not the rate limiting step in the viral entry process. This is consistent with highly efficient binding (i.e. large K a ) such that further increasing K a does not increase the fraction of cells with bound virus, F c , according to Fig. 3 . Hence C.V (through Eq. (3)) is constant and not rate-limiting, while a subsequent part of the infection process accommodated in p cell is less efficient than F c , such that p cell is very small and controls the overall value of p host according to Eq. (2). Indeed, the magnitude of K a is much more important when receptor binding is inefficient such as in the jumping of the species barrier into a novel host by an emerging virus as suggested by Gale (2017) . This is confirmed by Fig. 3 with F c increasing linearly with K a at lower K a values. Gale (2017) demonstrated that virus binding to its receptor is only important in controlling the probability of infection of a host cell if it is a major barrier, i.e. relatively inefficient. The K a for a virus jumping the species barrier into a novel host species would be expected to be very low perhaps due to electrostatic repulsion as for Scenarios A and B in Table 5 . The subsequent adaptation of the virus to its new host through mutation would increase K a as suggested here in Table 5 and reported for EBOV in humans (Diehl et al., 2016; Urbanowicz et al., 2016) .

The magnitude of ΔH a is largely controlled by how good the molecular fit is between the virus GP surface and the Cr surface and depends on hydrogen bonds and salt bridges. As shown in Table 5 , changes in ΔH a (ΔΔH a ) may be used to predict changes in K a providing the molecular basis of the GP/Cr interaction is available at atomic detail to enable some assessment of ΔΔH a . The infectivity of the new virus/ host combination relative to the "standard" virus/host would be directly proportional to the change in K a (as demonstrated from results in Table 2 ). Thus, thermodynamics provides the link between changes in the virus/host identified through sequencing data and the risk of infection. This in theory allows predictions of the infectivity of emerging virus strains or the susceptibility of novel hosts to be assessed on the basis of the effects of changes in sequence data. It is concluded that thermodynamic approaches have a major contribution to make in developing dose-response models for emerging viruses.

None declared.

The views expressed in this paper are those of the author and not necessarily those of any organisations.

pH-Induced denaturation of proteins: a single salt bridge contributes 3-5kcal/mol to the free energy of folding of T4 lysozyme

The organisation of Ebola virus reveals a capacity for extensive modular polyploidy

Association entropy in adsorption processes

How do filovirus filaments bend without breaking?

High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity

Homeostasis and function of goblet cells during rotavirus infection in mice

Membrane recognition by vesicular stomatitis virus involves enthalpy-driven proteinlipid interactions

Oligosaccharide multivalent lectin-carbohydrate interactions: energetics and mechanism of binding

Role of receptor binding specificity in influenza A virus transmission and pathogenesis

Qualitative and quantitative analysis of the binding of GII.4 Norovirus variants onto human blood group antigens

Ebola virus glycoprotein with infectivity dominated the 2013-2016 epidemic

Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions

Electrostatic contributions to T4 lysozyme stability: solventexposed charges versus semi-buried salt bridges

Intrinsic disorder in protein interactions: insights from a comprehensive structural analysis

Could bat cell temperature and filovirus filament length explain the emergence of Ebola virus in mammals? Predictions of a thermodynamic model

Application of omics approaches to the development of microbiological risk assessment using RNA virus dose-response models as a case study

The challenge of using experimental infectivity data in risk assessment for Ebola virus: why ecology may be important

Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells

Highly pathogenic influenza A (H5Nx) viruses with altered H5 receptor-binding specificity

Conducting the Dose-response assessment

How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza virus as an example

Long-term survival of an urban fruit bat seropositive for ebola and lagos bat viruses

The glycoproteins of all filovirus species use the same host factors for entry into bat and human cells but entry efficiency is species dependent

On the binding affinity of macromolecular interactions: daring to ask why proteins interact

Estimation of levels of salivary mucin, amylase and total protein in gingivitis and chronic periodontitis patients

Mass spectrometric analysis of mucin core proteins

Molecular basis of binding between novel human coronavirus MERS-CoV and its cellular receptor CD26

Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity

Mucin dynamics and enteric pathogens

Filovirus receptor NPC1 contributes to speciesspecific patterns of ebolavirus susceptibility in bats

Interactions of influenza virus with cultured cells: detailed kinetic modeling of binding and endocytosis

Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum

Principles and Problems in Physical Chemistry for Biochemists

Quantifying protein disorder through measures of excess conformational entropy

Glycan-receptor specificity as a useful tool for characterization and surveillance of influenza A virus

Cell density determines epithelial migration in culture

Structural analysis of histo-blood group antigen biding specificity in a Norovirus GII.4 epidemic variant: implications for epochal evolution

Entropic force between membranes reexamined

Carbohydrate recognition in cell adhesion and signaling

Dose response for infection by Escherichia coli O157:H7 from outbreak data

Human adaptation of Ebola virus during the West African outbreak

Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1

New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with ephrin-B2

TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope

Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions